Detailed monitoring of hematopoietic chimerism in a child treated by adoptive immunotherapy for high risk of relapse after BMT for acute myeloid leukemia

Bone Marrow Transplant. 2000 Feb;25(4):453-6. doi: 10.1038/sj.bmt.1702146.

Abstract

We report a case of a 13-year-old boy who was transplanted for relapse of acute myeloid leukemia (AML). A detailed study of hematopoietic chimerism was performed using polymerase chain reaction (PCR) of variable number of tandem repeats (VNTR) at very short time intervals. We used discontinuation of post-transplant immunosuppression and donor lymphocyte infusions (DLI) in order to prevent leukemia relapse that was indicated by a progressive increase in autologous hematopoiesis. Despite the fact that the boy relapsed 10 months after BMT, we could see a significant influence of adoptive immunotherapy on the mixed chimerism status during the post-transplant period.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adolescent
  • Bone Marrow Transplantation*
  • Combined Modality Therapy
  • Hematopoiesis* / genetics
  • Hematopoiesis* / immunology
  • Humans
  • Immunotherapy, Adoptive*
  • Leukemia, Myeloid / immunology
  • Leukemia, Myeloid / therapy*
  • Male
  • Secondary Prevention
  • Transplantation Chimera*
  • Transplantation, Homologous